Joshua D. Rosenblat

Toronto, ON, Canada

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 338 publications

The effect of ketamine on mitochondrial bioenergetics, viability, and function: A systematic review.

The effect of ketamine on mitochondrial bioenergetics, viability, and function: A systematic review.

Journal: Journal of psychopharmacology (Oxford, England)

Published: September 07, 2026

Serial Ketamine Infusions for Treatment-Resistant Bipolar Depression: A Randomized Clinical Trial.

Serial Ketamine Infusions for Treatment-Resistant Bipolar Depression: A Randomized Clinical Trial.

Journal: JAMA psychiatry

Published: September 02, 2026

Psychedelics Trials and Outcomes-A Closer Look.

Psychedelics Trials and Outcomes-A Closer Look.

Journal: JAMA psychiatry

Published: July 15, 2026

Evaluating the abuse liability of ketamine in the treatment of mood disorders: A systematic review.

Evaluating the abuse liability of ketamine in the treatment of mood disorders: A systematic review.

Journal: Journal of psychopharmacology (Oxford, England)

Published: June 24, 2026

Esketamine for major depressive disorder: pharmacokinetics and toxicological considerations.

Esketamine for major depressive disorder: pharmacokinetics and toxicological considerations.

Journal: Expert opinion on drug metabolism & toxicology

Published: May 06, 2026

Semaglutide and Effort-Based Decision-Making in Major Depressive Disorder: A Randomized Clinical Trial.

Semaglutide and Effort-Based Decision-Making in Major Depressive Disorder: A Randomized Clinical Trial.

Journal: JAMA psychiatry

Published: April 29, 2026

Blinding Integrity in Psychedelic Randomized Clinical Trials: A Systematic Review.

Blinding Integrity in Psychedelic Randomized Clinical Trials: A Systematic Review.

Journal: JAMA psychiatry

Published: April 15, 2026

Ketamine assisted psychotherapy to reduce chronic neuropathic pain: A mixed-methods randomized pilot trial.

Ketamine assisted psychotherapy to reduce chronic neuropathic pain: A mixed-methods randomized pilot trial.

Journal: Med (New York, N.Y.)

Published: April 14, 2026

The American Society of Clinical Psychopharmacology (ASCP) task force on the deprescribing of psychotropic medications for mood disorders: Delphi expert consensus.

The American Society of Clinical Psychopharmacology (ASCP) task force on the deprescribing of psychotropic medications for mood disorders: Delphi expert consensus.

Journal: The British journal of psychiatry : the journal of mental science

Published: March 25, 2026

Progress, potential and pitfalls of ketamine as a treatment for depression.

Progress, potential and pitfalls of ketamine as a treatment for depression.

Journal: Expert opinion on pharmacotherapy

Published: February 28, 2026

Recommendations for the Deprescribing of Psychotropic Medications: A Consensus Statement From the American Society of Clinical Psychopharmacology Task Force.

Recommendations for the Deprescribing of Psychotropic Medications: A Consensus Statement From the American Society of Clinical Psychopharmacology Task Force.

Journal: JAMA network open

Published: February 25, 2026

Intranasal Ketamine for Existential Distress in Advanced Cancer.

Intranasal Ketamine for Existential Distress in Advanced Cancer.

Journal: Journal of pain and symptom management

Published: January 31, 2026

Showing 1-12 of 338

Last Updated: 09/26/2026